Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer

NCT06709326 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT06709326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06709326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer
Lead sponsor
Umeå University
Phase
Not applicable
Overall status
Recruiting
Start date
September 29, 2020
Completion date
December 31, 2025
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer